Skip to main content

Table 1 Demographics and sample characteristics

From: Prospective observational cohort study of ‘treatment as usual’ over four years for patients with schizophrenia in a national forensic hospital

  Full sample (n = 69) Less than 2112 days (n = 35) More than 2112 days (n = 34)
\( \overline{x} \) M S.D. \( \overline{x} \) M S.D. \( \overline{x} \) M S.D.
Age 39.72 38.00 11.13 34.11 33.00 6.91 45.50 43.50 11.77
DUNDRUM-1 triage security (0–4) 3.03 3.00 0.47 2.95 3.00 0.55 3.07 3.06 0.38
Length of stay at baseline (years) 7.94 5.00 8.71 2.54 3.00 1.96 13.50 11.00 9.46
Length of follow-up (years) 3.42 4.00 1.32 3.03 4.00 1.62 3.82 4.00 0.76
MCCB composite (t-score) 21.09 21.00 14.21 19.68 16.00 14.34 22.53 23.50 14.14
PANSS total score 64.27 60.00 21.80 67.74 63.00 25.79 60.71 58.50 16.36
PANSS positive 14.31 12.00 7.98 15.41 13.00 9.38 13.22 11.50 6.23
PANSS negative 19.08 18.50 7.86 18.69 18.00 8.25 19.47 19.00 7.56
CPZeq (mg/day) 529.57 467.00 341.92 526.66 500.00 284.27 532.58 458.50 397.03
  1. Note: \( \overline{x} \) mean, SD standard deviation, M median, MCCB MATRICS consensus cognitive battery, PANSS Positive and Negative Syndrome Scale, CPZeq Chlorpromazine equivalent